• Paroxetine Mesylate: Advanced SSRI Workflows & Oncology Insi

  2026-06-23

  Paroxetine Mesylate redefines research by pairing potent selective serotonin reuptake inhibition with multi-kinase activity, enabling robust workflows in neuropsychiatric, oncology, and translational cardiac biomarker research. Discover protocol enhancements, cross-domain applications, and troubleshooting strategies that empower reproducible, high-impact results.

• S-Adenosylmethionine (SAM): Reliable Methyl Donor for Assays

  2026-06-23

  This article provides actionable, scenario-driven guidance for bench scientists and biomedical researchers seeking reliable performance in methylation-dependent assays. Drawing on real laboratory challenges, it demonstrates how S-Adenosylmethionine (SAM) (SKU B3513) offers data-backed reliability, protocol flexibility, and workflow efficiency, supported by peer-reviewed evidence and vendor transparency.

• Epinephrine Bitartrate: Validated Adrenergic Receptor Agonis

  2026-06-22

  Epinephrine Bitartrate is a potent, non-selective adrenergic receptor agonist used for both fundamental research and clinical interventions. Its well-defined EC₅₀ parameters, robust solubility, and documented efficacy in vasoconstriction and bronchodilation make it a benchmark compound for sympathetic nervous system research and cardiovascular disease studies.

• Cyclo (-RGDfC) in Translational Tumor Targeting: Mechanisms

  2026-06-22

  Explore how Cyclo (-RGDfC), a cyclic peptide targeting integrin αvβ3, is advancing cancer research through precise tumor cell targeting and robust assay design. This article reveals novel mechanistic insights and practical parameters for integrin-mediated studies, distinguishing itself with translational guidance for innovative workflows.

• Deferoxamine Mesylate: Iron Chelation and Ferroptosis Precis

  2026-06-21

  Explore the mechanistic depth of Deferoxamine mesylate as a targeted iron-chelating agent for oxidative stress and ferroptosis research. This article reveals new insights into its impact on membrane remodeling and practical assay design.

• GPNMB-Based Multimodal Model Predicts Immunotherapy Response

  2026-06-20

  This study presents a clinically validated, circulating GPNMB-based multimodal model that predicts immunotherapy response in esophageal squamous cell carcinoma (ESCC). By integrating plasma proteomics, tumor microenvironment features, and clinical data, the model offers a robust approach for patient stratification in precision immunotherapy.

• Pol II Degradation Triggers Cell Death Independent of Transc

  2026-06-19

  The referenced study uncovers that degradation of RNA Polymerase II (Pol II) activates cell death pathways independently of its canonical role in transcription. This finding challenges longstanding assumptions about cell viability dependence on transcription and holds particular relevance for mechanistic cancer research and apoptosis assays.

• Pazopanib (GW-786034): Applied Protocols in Cancer Research

  2026-06-19

  Pazopanib (GW-786034) enables precise angiogenesis inhibition and tumor growth suppression in advanced cancer models, especially those with ATRX deficiency. This guide delivers actionable workflow enhancements, troubleshooting strategies, and literature-driven insights to optimize your experimental outcomes.

• Region-Specific Uptake of Milk EVs in Intestinal Stem Cell O

  2026-06-18

  This study provides the first comprehensive analysis of milk-derived extracellular vesicle (MEV) uptake and function in physiologically relevant porcine intestinal stem cell–based organoid models. By delineating region- and polarity-specific internalization mechanisms, the research advances understanding of how MEVs modulate intestinal stemness and differentiation, offering valuable insights for membrane trafficking and endocytosis research.

• LAMP1 Modulates CXCL10-CXCR3 Axis and Macrophage Polarizatio

  2026-06-18

  The reference study uncovers how LAMP1 acts as a molecular switch in the CXCL10-CXCR3 axis, determining macrophage polarization direction under inflammatory and non-inflammatory conditions. This work provides mechanistic clarity on CXCR3 antagonist effects and highlights AMG 487’s context-dependent influence on inflammation and lung injury.

• Phosphotungstic Acid Negative Stain Solution for Advanced Vi

  2026-06-17

  Phosphotungstic Acid Negative Stain Solution (2%) offers unmatched clarity in electron microscopy, enabling high-contrast visualization of viruses, macromolecules, and glycan vulnerabilities. With robust protocol flexibility and proven performance in glycoprotein analysis, this reagent is indispensable for next-generation virology and antiviral research.

• Everolimus (RAD001): Deeper Insights into mTOR Inhibition an

  2026-06-17

  Explore Everolimus (RAD001) as a precision mTOR inhibitor for cancer research. This article uncovers advanced mechanistic insights and practical guidance for optimizing apoptosis and proliferation assays, grounded in recent scientific advances.

• Evaluating Topotecan and Carboplatin Regimens in Ovarian Can

  2026-06-16

  The referenced Cochrane review systematically assesses the efficacy and safety of adding topotecan to standard carboplatin/paclitaxel chemotherapy for ovarian cancer. The findings clarify that topotecan does not significantly improve survival outcomes, informing researchers’ design of future preclinical and translational studies.

• HDAC Inhibition as a Strategy to Repress NUT Function in Car

  2026-06-16

  Shiota et al. present a high-throughput chemical screen that identifies diverse histone deacetylase (HDAC) inhibitors as effective repressors of NUT transcriptional activity in NUT carcinoma. Their findings implicate HDAC inhibition as a promising therapeutic approach and provide mechanistic insights into the regulation of oncogenic megadomain function.

• Cefodizime in Research: Precision, Stability, and Immunomodu

  2026-06-15

  Explore Cefodizime, a third-generation cephalosporin antibiotic, through the lens of advanced research design. This article uniquely highlights its precision in bacterial cell wall inhibition, stability against β-lactamases, and immunomodulatory potential, offering practical guidance for innovative microbiology assays.

542 records 13/37 page Previous Next First page 上5页 1112131415 下5页 Last page